JNJ

Johnson and Johnson Stock Price

147.80
0.25 (0.17%)
147.80
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Johnson and Johnson JNJ NYSE Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
0.25 0.17% 147.80 0.00 0.00 0.00 147.55 08:48:40
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
151 7,259 $ 147.68 $ 1,072,030 6,751,780 109.16 - 157.00
Last Trade Time Type Quantity Stock Price Currency
08:48:40 formt 392 $ 147.80 USD

Johnson and Johnson Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 388.60B 2.63B 2.63B $ 82.06B $ 15.41B 5.63 25.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
12.51M $ 3.75 2.54% - -

more financials information »

Johnson and Johnson News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical JNJ Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week146.96150.70143.96147.095,358,2060.840.57%
1 Month142.75151.88141.425147.526,073,9335.053.54%
3 Months147.58153.62137.02145.406,906,6250.220.15%
6 Months153.34157.00109.16140.579,327,465-5.54-3.61%
1 Year129.36157.00109.16138.588,202,78618.4414.25%
3 Years133.09157.00109.16136.087,058,82514.7111.05%
5 Years99.22157.0081.79127.146,768,01248.5848.96%

Johnson and Johnson Description

Johnson & Johnson is the world's largest and most diverse healthcare company. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total revenue is generated in the United States.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.